Max Robotics — Global Service Robot Directory + US Certification

About

Nahid Golabi is a clinical researcher whose work sits at the intersection of head and neck oncology and patient-centered outcomes, with a particular focus on human papillomavirus-associated oropharyngeal squamous cell carcinoma (HPV-OPSCC). Their research has made meaningful contributions to the growing movement toward treatment deintensification — exploring whether patients with HPV-related oropharyngeal cancer can achieve comparable oncologic outcomes while experiencing fewer debilitating side effects. Central to Golabi's portfolio is the investigation of neoadjuvant chemotherapy combined with transoral robotic surgery (TORS) as an innovative alternative to traditional radiation-based regimens, which are known to impose significant short- and long-term toxicities on patients. A consistent thread across their work is the rigorous assessment of quality of life outcomes, recognizing that survivorship and functional well-being are as critical as disease control. Golabi has also addressed the persistent challenge of distant metastasis, which remains the leading cause of mortality in this patient population. With a growing citation record — including a 2023 paper already accumulating 13 citations — Golabi's research is gaining traction among clinicians and researchers actively reshaping the standard of care for oropharyngeal cancer patients.